Pearlstein Teri, Howard Margaret, Salisbury Amy, Zlotnick Caron
Department of Psychiatry and Human Behavior, The Warren Alpert Medical School of Brown University, Women and Infants Hospital, Providence, RI, USA.
Am J Obstet Gynecol. 2009 Apr;200(4):357-64. doi: 10.1016/j.ajog.2008.11.033.
Postpartum depression (PPD) affects up to 15% of mothers. Recent research has identified several psychosocial and biologic risk factors for PPD. The negative short-term and long-term effects on child development are well-established. PPD is under recognized and under treated. The obstetrician and pediatrician can serve important roles in screening for and treating PPD. Treatment options include psychotherapy and antidepressant medication. Obstacles to compliance with treatment recommendations include access to psychotherapists and concerns of breastfeeding mothers about exposure of the infant to antidepressant medication. Further research is needed to examine systematically the short-term and long-term effect of medication exposure through breastmilk on infant and child development.
产后抑郁症(PPD)影响着多达15%的母亲。最近的研究已经确定了PPD的几个心理社会和生物学风险因素。其对儿童发育的短期和长期负面影响已得到充分证实。PPD未得到充分认识和治疗。产科医生和儿科医生在筛查和治疗PPD方面可以发挥重要作用。治疗选择包括心理治疗和抗抑郁药物。遵守治疗建议的障碍包括难以获得心理治疗师以及母乳喂养母亲担心婴儿接触抗抑郁药物。需要进一步研究,以系统地检查通过母乳接触药物对婴幼儿发育产生的短期和长期影响。